Abstract | PURPOSE: PATIENTS AND METHODS: The study included 60 SACC patients, equally divided between nonmetastatic SACC and metastatic SACC. We used 30 NSG samples as the control. The expression of cytokines was studied by immunohistochemistry and compared using the integrated optical density. The relationship between NRP1, NRP2, VEGF-A, and Sema-3A expression and microvessel density (MVD) was analyzed in the 3 groups. RESULTS: In metastatic SACC, the expression levels of NRP1 and VEGF-A were significantly greater than those in nonmetastatic SACC and NSG. The expression of Sema-3A and Sema-3F was significantly lower in metastatic SACC than that in nonmetastatic SACC and NSG (P < .0001). No significant differences were found in NRP2 expression among the 3 groups (P = .43). The MVD of metastatic SACC was significantly greater than that of nonmetastatic SACC and NSG (P < .0001). However, the lymphatic vessel density of the 3 groups was not significantly different statistically. The relationship between MVD and NRP1 or VEGF-A showed a significant positive correlation (P < .0001, for both). However, a significant negative correlation was found between the MVD and Sema-3A or Sema-3F expression (P < .0001, for both). CONCLUSIONS: Hematogenous metastasis of SACC is correlated with high expression of NRP1 and VEGF-A and low expression of Sema-3A and Sema-3F. The increased numbers of microvessels induced by VEGF-A signaling, combined with NRP1, could be one of the key reasons leading to the enhanced hematogenous metastasis in SACC.
|
Authors | Qianwei Ni, Jinlong Sun, Chao Ma, Yun Li, Jun Ju, Moyi Sun |
Journal | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
(J Oral Maxillofac Surg)
Vol. 76
Issue 3
Pg. 569-579
(03 2018)
ISSN: 1531-5053 [Electronic] United States |
PMID | 28961428
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Membrane Proteins
- NRP1 protein, human
- Nerve Tissue Proteins
- Neuropilin-2
- Neuropilins
- SEMA3A protein, human
- SEMA3F protein, human
- Semaphorin-3A
- Vascular Endothelial Growth Factor A
- neuropilin-2, human
- Neuropilin-1
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Adenoid Cystic
(metabolism, pathology)
- Humans
- Male
- Membrane Proteins
(metabolism)
- Middle Aged
- Nerve Tissue Proteins
(metabolism)
- Neuropilin-1
(metabolism)
- Neuropilin-2
(metabolism)
- Neuropilins
(metabolism)
- Salivary Gland Neoplasms
(metabolism, pathology)
- Salivary Glands
(metabolism)
- Semaphorin-3A
(metabolism)
- Vascular Endothelial Growth Factor A
(metabolism)
|